// Neurotechnology

All signals tagged with this topic

Apr 24

Johns Hopkins Identifies the Neurological Cause of 3pm Productivity Collapse

Research identifies a biological mechanism behind the afternoon slump rather than a behavioral or motivational failure. This shifts responsibility from individual willpower to workplace design. Companies that accommodate circadian dips through scheduling, break policies, or task management gain a measurable advantage over those treating the 3pm crash as a personal failing. For consumer brands, the 3pm energy deficit creates documented demand for products that genuinely restore alertness—from functional beverages to productivity software designed around biological rhythms rather than against them.

theme-ai Neurotechnology Ethics

Apr 23

Startup Claims Lab-Grown Sperm Used to Create Embryos

Source: WIRED

Paterna Biosciences claims it can reprogram stem cells into functional sperm and has used that sperm to generate embryos. If verified, the capability moves from theoretical to operational and bypasses the biological requirement for male gamete production entirely. The immediate applications are clear: infertile men and same-sex couples gain a fertility option. The harder questions are regulatory—no FDA pathway exists for lab-derived gametes—and evidentiary: whether peer review or live births will constitute proof. The startup model itself matters. Private capital is now funding reproductive infrastructure that governments have either banned or left in legal limbo, creating a race condition where technical capability outpaces governance.

theme-connected energy Neurotechnology

Apr 17

Energy and neural control emerge as optimization frontiers

Source: Not Boring

Not Boring's survey identifies two concrete technical domains: energy systems (generation, storage, and grid efficiency) and non-invasive brain-body interfaces that bypass pharmaceutical or surgical intervention. Both represent a shift from accepting biological and infrastructural constraints to actively optimizing them—one at civilization scale, one at the individual level. Venture and research capital are tracking toward systems that enhance rather than maintain. The "non-molecular" framing signals growing confidence in magnetic, electrical, and acoustic methods over drug-based approaches, a shift in how technologists weigh invasiveness tradeoffs.

theme-ai AI & ML Neurotechnology

Apr 6

Elite creativity has a measurable neural signature, not raw intelligence

Source: Neuroathletics

A Nature-published study across multiple research centers has isolated the specific brain activation patterns that distinguish creative high performers from those with equivalent IQ, upending decades of assumptions that intelligence alone drives creative output. Organizations should reconsider how they screen for creative talent—moving from IQ proxies (standardized tests, credential stacking) toward behavioral or neuroimaging markers that actually correlate with novel problem-solving. Hiring, talent development, and educational curricula built on intelligence metrics alone will look increasingly crude against biometric evidence of what the brain actually does when generating ideas.

theme-connected hardware Neurotechnology

Apr 1

Brain implant patient plays music through thought alone

Source: Wired

Caltech’s BCI trial has moved beyond cursor control and communication into creative expression—Galen Buckwalter can now produce musical tones directly from neural signals, a practical demonstration that brain-computer interfaces must deliver genuine pleasure, not just function, to justify the surgical risks and maintenance burden they impose. Early users won’t tolerate devices that merely restore lost capability if competitors offer richer experiences, so the technology’s viability depends on expanding into domains (music, art, gaming) where healthy people might voluntarily adopt implants. Whoever cracks the “enjoyable BCI” problem first will own the consumer market, not just the medical one.

theme-connected Neurotechnology Wearables

Apr 1

Finnish startup weaponizes brainwave audio for phoneless institutions

Source: The Next Web

Audicin’s $1.9M raise addresses a concrete market gap: secure facilities (prisons, hospitals, military bases) where inmates and patients need wellness interventions but smartphones are contraband. By embedding neurotechnology in a headband rather than an app, the company builds infrastructure for environments that have been largely ignored by the consumer wellness boom—turning regulatory friction into a defensible distribution channel. Oura Health’s backing indicates that biometric companies see institutional health monitoring, not just consumer self-tracking, as the next growth area for wearables.